'Healthcare is grossly under-engineered,' says Johns Hopkins' Pronovost (podcast)

January 18, 2013 by Arezu Sarvestani

Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.

Peter Pronovost of Johns Hopkins Medical

Healthcare providers are looking to medical devices to play a new role in hospital care, providing a whole-patient view of health through technologies that talk to each other and help clinicians make decisions about treatment.

Dr. Peter Pronovost, a critical care physician and anesthesiologist as well as Johns Hopkins Medicine senior vice president for patient safety & quality, told MassDevice.com that healthcare has yet to make the kind of progress innovative technologies have brought to other industries.


MassDevice.com podcast

Click to play

"Ironically, healthcare has invested significantly in technology, but it's the only industry for which technology hasn't helped productivity or safety," Pronovost told us. "In part, that's because we've invested in individual devices, but we haven't looked at integrating them as systems."

Sign up to get our free newsletters delivered right to your inbox.

Our conversation with Pronovost followed his appearance at the Patient Safety, Science & Technology Summit in Laguna Beach, Calif., last Sunday and Monday, where he and other healthcare stakeholders asked medical device makers to pledge to open up their devices to share data and develop interoperability around patient care and monitoring.

Comments

Features

ResMed CEO Mick Farrell tells MassDevice.com about the history of ResMed, its sleep apnea devices and the future of treating chronic disease.

Dr. Robert Greenberg, founder & CEO of Second Sight Medical, chats with MassDevice.com in advance of his appearance at the Big 100 West to discuss the Argus II 'bionic eye.'

CEO Josh Kornberg tells MassDevice.com about cleaning house and how bad news for rival Stryker Corp. is helping to reinvigorate Skyline Medical.

In this MassDevice.com podcast, we speak with Glooko CEO Rick Altinger about the company's mobile diabetes management application for smartphones and how it has the potential to change the spectrum of care for one of the world's most common chronic diseases.

Renal denervation has won a lot of praise as a potential solution for patients with resistant hypertension, but the excessive celebration of early clinical trial results may be setting everyone up for a major letdown and a harsh backlash. This week cardiologists at the Transcatheter Cardiovascular Therapeutics conference, including those involved with Medtronic's and Boston Scientific's clinical trials, warned of the dangers of exaggeration.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp